刘兵城 - Leukemia center Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences

基本信息

浏览量：114

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 175 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Measurable Residual Disease Recurrence As Early Warning of Relapse in Acute Myeloid Leukemia

Benfa Gong,Miao Yang,Shaowei Qiu,Bingcheng Liu,Ying Wang,Yingchang Mi,Hui Wei,Jianxiang Wang

Haematologicapp.0-0, (2025)

引用0浏览0WOS引用

Clinical Features and Treatment Response to TKIs in Chronic Myeloid Leukemia Patients with Atypical BCR::ABL1 Transcripts

Haoren Wang, Cong Han,Benfa Gong,Yuntao Liu,Kaiqi Liu,Runxia Gu,Ying Wang,Hui Wei,Yingchang Mi,Bingcheng Liu,Jianxiang Wang

Leukemia research (2025): 107733-107733

引用0浏览0WOS引用

Dynamin2 Mutations in Newly Diagnosed Acute Myeloid Leukemia: Clinical Characteristics, and Prognostic Significance

Kunpeng Luo,Jiayuan Chen, Wenting Wang, Yan Hui,Shaowei Qiu,Bingcheng Liu,Yingchang Mi,Jianxiang Wang,Hui Wei

Experimental Hematology & Oncologyno. 1 (2025): 1-5

引用0浏览0WOS引用

Prognostic Impact of Co-Mutations in Adults with IDH1/2-mutated Acute Myeloid Leukemia

Anli Lai, Wenbing Liu,Chunlin Zhou,Yan Li,Shuning Wei,Kaiqi Liu,Benfa Gong,Xiaoyuan Gong,Yuntao Liu,Guangji Zhang, Junping Zhang,Runxia Gu,Shaowei Qiu,Bingcheng Liu,Ying Wang,Hui Wei,Yingchang Mi,Jianxiang Wang

Blood science (Baltimore, Md)no. 2 (2025): e00231-e00231

引用0浏览0WOS引用

Patient-reported Outcomes in Adults with Tyrosine Kinase Inhibitor-Resistant Chronic Myeloid Leukemia Receiving Olverembatinib Therapy

Lu Yu,Weiming Li,Na Xu,Xiaoli Liu,Bingcheng Liu,Yanli Zhang,Li Meng,Huanling Zhu,Xin Du,Suning Chen,Yu Hu,Yongping Song,Lichuang Men,Qian Jiang

CANCER（2025）

引用0浏览0WOS引用

KMT2C/D Mutations in Newly Diagnosed Acute Myeloid Leukaemia: Clinical Features, Genetic Co-Occurrences and Prognostic Significance

Wenting Wang,Miao Yang,Xue Zhang,Jiayuan Chen,Shaowei Qiu,Bingcheng Liu,Yingchang Mi,Jianxiang Wang,Hui Wei

Clinical and translational medicineno. 4 (2025): e70284-e70284

引用0浏览0WOS引用

Ponatinib 2-Year Efficacy, Safety and Health-Related Quality of Life in Patients with Philadelphia Chromosome-Positive Leukemia: an Open-Label, Multicenter, Phase 2 Clinical Trial in China

Lu Yu, Huifang Wang, Xiaoli Liu,Bingcheng Liu,Xielan Zhao,Qun He,Qingshu Zeng,Zimin Sun,Ting Liu,Huanling Zhu,Zhuogang Liu,Xin Du,Jie Jin,Li Meng,Ming Hou, Suning Chen,Linhua Yang, Mingji Xian, Yoshitaka Kotobuki, Shuang Zhang,Qian Jiang

BLOOD (2024): 6602-6603

引用0浏览0引用

Safety and Efficacy of Tgrx-678, a Potent BCR::ABL1 Allosteric Inhibitor, in Patients with Tyrosine Kinase Inhibitor Resistant And/or Intolerant Chronic Myeloid Leukemia: Updated Results of Phase 1 Study Tgrx-678 -1001

Qian Jiang, Li Weiming,Yanli Zhang, Qiang Wang,Suning Chen,Bingcheng Liu,Zhuogang Liu,Jie Jin,Zhenfang Liu,Jianyu Weng,Xin Du,Xielan Zhao,Li Meng,Lie Lin, Wanlin Ye, Shujie Yan,Yihan Wang, Jingrong Cao

Bloodno. Supplement 1 (2024): 477-477

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn

Bingcheng Liu(刘兵城)

论文共 175 篇作者统计合作学者相似作者